F00-F99
Conditions
Interventions
Group 1: patients with usual care = patients of the control group
Group 2: Patient that benefits from pharmaceutical care supplemental to the usual care = Patients of the intervention phase
Sponsors
Professur für Molekulare und Klinische Pharmazie, Friedrich-Alexander-Universität Erlangen-Nürnberg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: -Patients admitted on open wards P21 and P31 independent of their diagnosis - age>17 - Possibility to independently complete questionnaires -possibility to understand written and spoken German - soundness of mind - hospital stay more than 7 days - willingness to be contacted after discharge
Exclusion criteria
Exclusion criteria: - merely psychotherapeutic treated patients without applied drugs (non-psychatric) - patiens being transfered from the acute ward for women (P12) to the open wards
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of unsolved Drug related problems (DRP) per patient after the patient finished the study plan (planned time frame: mean time of psychiatric hospital stay in the Departement of Psychiatry and Psychotherapy in Erlangen of 21 days + last patient contact 3 months after discharge (approximately 90 days) = 111 days per Patient) between control and intervention group. Patient adherence according to the German version of the Medication Adherence Report Scale compared ad admission, discharge and 3 months after discharge between control and intervention group | — |
Secondary
| Measure | Time frame |
|---|---|
| - Number of solved and unsolved DRP at discharge and 3 months after discharge between control- and intervention group - Attitude of the patients regarding their psychotropic medication (Drug Attittude Inventory) at admission, discharge and 3 months after discharge between control- and intervention group, - Impact of the Attitude of the Patient regarding its psychotropic medication on adherence at admission, discharge and 3 months after discharge - prevalence of side effects assessed with the UKU side effect rating scale at admission, discharge and 3 months after discharge - Influence of assessed weight changes/ADE on the attitude according to psychotropic drugs (discharge, 3 months after discharge) - Influence of assessed weight changes/ADE onadherence of the patients (discharge, 3 months after discharge) - Influence of the number of medication on adherence (admission, discharge, 3 months after discharge) - Influence of the number of medication on the number of detected DRP (admission, discharge, 3 months after discharge) - Comparison of the weight changes between control and intervention group at admission, discharge, 3 months after discharge - Patients' satisfaction with pharmaceutical care after the patients terminate the study plan (Questionnaire: "Assessement of the pharmaceutical care service", developed by PhD Sonja Koch in the course of her study "A pilot study regarding pharmaceutical care of patient with coronary heart disease", descriptiv, only patients of the intervention group) | — |
Countries
Germany
Contacts
Public ContactKristina Friedland
Professur für Molekulare und Klinische Pharmazie, Friedrich-Alexander-Universität Erlangen-Nürnberg
Outcome results
None listed